New Key Statistics Module, Z-Score and F-Score
OTCPK:MBGPF Key Ratios
| Market Cap $ M | 52.86 |
| Enterprise Value $ M | 30.63 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.76 |
| Price/Sales | 30.52 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -0.05 |
| Beneish M-Score | -1.79 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -17.03 |
| EV-to-EBITDA | -18.80 |
| PEG | -- |
| Shares Outstanding M | 47.18 |
| Net Margin (%) | -128.96 |
| Operating Margin % | -119.54 |
| Pre-tax Margin (%) | -102.57 |
| Quick Ratio | 12.05 |
| Current Ratio | 12.25 |
| ROA % (ttm) | -3.13 |
| ROE % (ttm) | -3.23 |
| ROIC % (ttm) | -4.31 |
| Dividend Yield % | -- |
| Altman Z-Score | 15.30 |
MBGPF Number of Guru Trades
MBGPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:MBGPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:MBGPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Moberg Pharma AB Insider Transactions
No Available Data
News about OTCPK:MBGPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers